Ayala Ventures

Ayala Ventures is the venture entity of Ayala Corporation, one of the Philippines’ largest and oldest conglomerates, with growth-stage checks of $25M and up into healthcare and adjacent sectors. Ayala has been a major force behind expanding Philippine healthcare access, including significant interests in clinics, hospitals, pharmacies, and digital infrastructure, which shapes the strategic lens of the venture entity. The right counterparty is a CEO or sponsor of a healthcare business that Ayala can integrate into or accelerate via its existing healthcare and digital platforms; this is corporate-strategic growth capital rather than financial venture. Healthcare relevance includes clinic and hospital networks at scale, pharma and therapeutics with branded portfolios, tech-enabled care delivery with proven economics, and platforms that benefit from access to Ayala’s distribution, telecommunications, and financial services ecosystem. Founders raising sub-$25M, pre-Series B, or building software-only experiments should look elsewhere. Geographic advantage is the Ayala network: Globe Telecom for digital reach, BPI for financial services, AC Health for clinical infrastructure, and the broader real estate and retail platforms that touch Filipino consumers daily. For the right healthcare CEO, this is some of the deepest distribution in Southeast Asia. The flip side is corporate governance complexity, longer decision cycles tied to the parent’s strategic planning, and the strategic-investor playbook around exclusivity and future-round language. Best entry is via Ayala’s corporate development and venture teams, AC Health relationships, or warm referrals from CEOs who have actually executed pilots inside the Ayala ecosystem. Cold inbound rarely converts at this scale. Lead the pitch with the strategic fit, audited financials, regulator and clinical quality posture, and a clear thesis on how an Ayala partnership accelerates the business. Be explicit about the entity within Ayala that is investing, governance expectations, and how the relationship is structured to preserve future financing optionality. Caveats: negotiate hard on right-of-first-refusal, exclusivity, and any MFN provisions, since later financial investors will scrutinize these. Confirm whether the check is fund-structured or balance-sheet, and how follow-on is handled. Ask about leadership continuity and how the relationship survives changes in Ayala’s strategic priorities, which can shift over multi-year horizons. Reference checks with current Ayala portfolio CEOs on commercial value realized are essential. Used appropriately, Ayala Ventures is one of the most strategic growth partners available in the Philippines for healthcare CEOs ready for that scale; for earlier-stage founders, it is premature.